Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bo Cheng

Showing results (1211-1220 of 1,244) with videos related to

Pageof 125
Sort By:
International Journal of Surgery (London, England)|September 27, 2023
Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort studyHongsheng Deng, Juan Zhou, Hualin Chen, et al.
NPJ Vaccines|November 20, 2025
To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunizationEn-Shuo Liu, Kai-Wen Ho, Chin-Chung Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 24, 2024
Advanced High-Throughput Rational Design of Porphyrin-Sensitized Solar Cells Using Interpretable Machine LearningJian-Ming Liao, Yu-Hsuan Chen, Hsuan-Wei Lee, et al.
International Journal of Biological Macromolecules|February 20, 2025
Development of a tumor-region-selective activation monoclonal antibody targeting the 4-1BB receptor for enhanced therapeutic efficacy and safetyTzu-Yi Liao, Yen-Ling Liu, Chiao-Yun Chen, et al.
Medicine|June 3, 2020
Study on efficacy and safety of Huangqi Guizhi Wuwu decoction treatment for oxaliplatin induced peripheral neurotoxicity: A protocol for a randomized, controlled, double-blind, multicenter trialXiao-Man Wei, Xiao-Feng Chen, Peng Shu, et al.
ACS Nano|September 28, 2020
Artificial Nanotargeted Cells with Stable Photothermal Performance for Multimodal Imaging-Guided Tumor-Specific TherapyBin Qiao, Yuanli Luo, Hong-Bo Cheng, et al.
Plos Pathogens|March 17, 2023
Negative regulation of type I interferon signaling by integrin-linked kinase permits dengue virus replicationYi-Sheng Kao, Li-Chiu Wang, Po-Chun Chang, et al.
International Journal of Biological Macromolecules|February 27, 2026
Selective activation of pro-anti-CTLA-4 antibody maintains therapeutic efficacy and reduces immune-related adverse eventsBo-Cheng Huang, Shih-Ting Hong, Tzu-Yi Liao, et al.
BMJ Open Respiratory Research|December 4, 2024
Association of pre-existing conditions with major driver mutations and PD-L1 expression in NSCLCPeiling Chen, Xin Zheng, Caichen Li, et al.
Zoological Research|July 17, 2022
Whole-genome resequencing reveals molecular imprints of anthropogenic and natural selection in wild and domesticated sheepDe-Yin Zhang, Xiao-Xue Zhang, Fa-Di Li, et al.
Pageof 125

Showing results (1211-1220 of 1,244) with videos related to

Sort By:
Pageof 125
International Journal of Surgery (London, England)|September 27, 2023
Impact of lymphadenectomy extent on immunotherapy efficacy in postresectional recurred non-small cell lung cancer: a multi-institutional retrospective cohort studyHongsheng Deng, Juan Zhou, Hualin Chen, et al.
NPJ Vaccines|November 20, 2025
To generate functional anti-protease-activated receptor-4 (PAR4), a G protein-coupled receptor, antibodies through PAR4-mRNA-LNP immunizationEn-Shuo Liu, Kai-Wen Ho, Chin-Chung Wu, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 24, 2024
Advanced High-Throughput Rational Design of Porphyrin-Sensitized Solar Cells Using Interpretable Machine LearningJian-Ming Liao, Yu-Hsuan Chen, Hsuan-Wei Lee, et al.
International Journal of Biological Macromolecules|February 20, 2025
Development of a tumor-region-selective activation monoclonal antibody targeting the 4-1BB receptor for enhanced therapeutic efficacy and safetyTzu-Yi Liao, Yen-Ling Liu, Chiao-Yun Chen, et al.
Medicine|June 3, 2020
Study on efficacy and safety of Huangqi Guizhi Wuwu decoction treatment for oxaliplatin induced peripheral neurotoxicity: A protocol for a randomized, controlled, double-blind, multicenter trialXiao-Man Wei, Xiao-Feng Chen, Peng Shu, et al.
ACS Nano|September 28, 2020
Artificial Nanotargeted Cells with Stable Photothermal Performance for Multimodal Imaging-Guided Tumor-Specific TherapyBin Qiao, Yuanli Luo, Hong-Bo Cheng, et al.
Plos Pathogens|March 17, 2023
Negative regulation of type I interferon signaling by integrin-linked kinase permits dengue virus replicationYi-Sheng Kao, Li-Chiu Wang, Po-Chun Chang, et al.
International Journal of Biological Macromolecules|February 27, 2026
Selective activation of pro-anti-CTLA-4 antibody maintains therapeutic efficacy and reduces immune-related adverse eventsBo-Cheng Huang, Shih-Ting Hong, Tzu-Yi Liao, et al.
BMJ Open Respiratory Research|December 4, 2024
Association of pre-existing conditions with major driver mutations and PD-L1 expression in NSCLCPeiling Chen, Xin Zheng, Caichen Li, et al.
Zoological Research|July 17, 2022
Whole-genome resequencing reveals molecular imprints of anthropogenic and natural selection in wild and domesticated sheepDe-Yin Zhang, Xiao-Xue Zhang, Fa-Di Li, et al.
Pageof 125